PDCD1 and cancer: Elevated levels of PD-1 are correlated with increased T cell exhaustion, but also facilitates the success of anti-PD-1 checkpoint therapy, contributing to increased overall survival of obese cancer patients treated with anti-PD-1 antibodies (24).